Copd Treatment

Overview Forums Topics Doctor Questions eHealthpedia
Ask our Community
Members
eHealthpedia Articles
Asthma Diagnosis
Who do you see to diagnose asthma? And what diagnostic tests can you expect. Click here to learn how to get a correct asthma diagnosis.
High Blood Pressure Causes and Risk Factors
Hypertension can be caused by a number of underlying medical conditions. Which ones? Are you at risk of developing high blood pressure?
Pneumonia Causes and Risk Factors
Some people are more at risk of getting pneumonia than others. Are you one of them? Learn more about how you get pneumonia and who is at risk here.
Conditions and Diseases Screening
Learn about screening and diagnosis options available for certain conditions and diseases.
More
Topics
St_ephen
St_ephen / Lungs and Respiratory Disorders
polenglish
polenglish / Lungs and Respiratory Disorders
More
Medical Experts
Dr. Kokil Mathur
General Medicine
anandsingh
General Medicine & Surgery
Madhumita Paul
General Medicine, Women's Health
Doctor Answers
Madhumita Paul
Madhumita Paul / Blood Disorders
Dr. Ana Aleksovska
Dr. Ana Aleksovska / Lungs and Respiratory Disorders
Dr. Kokil Mathur
Dr. Kokil Mathur / Asthma
Dr. Ana Aleksovska
Dr. Ana Aleksovska / Lungs and Respiratory Disorders
More
News
Elevation reports positive results for COPD treatment
The successful phase 2 clinical trial results allowed the San Diego drug developer to collect the final $17 million portion of $30 million promised by investors during a fund-raising round in early 2010.
Gene Research, Banned Inhalers Change Asthma, COPD Treatment Options
U.S. researchers are using genetics to explain why some asthma sufferers do not respond well to steroid inhalers, the most common form of asthma treatment. Over-the-counter inhalers that use CFCs have also been banned. Here are some facts about asthma, Ch
Pearl Therapeutics' Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva®
REDWOOD CITY, Calif., Sept. 26, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. presented additional positive results from its  Phase 2b study (NCT01085045) demonstrating that the dual bronchodilator combination product, PT003 (GFF MDI) provides superior in
Underweight COPD patients at higher risk of death
Patients suffering from chronic obstructive pulmonary disease (COPD) are at a higher risk of death if they are underweight.
NVA237 Filed in Europe and Positive Phase III Data at European Respiratory Society Congress
TOKYO, September 27, 2011 /PRNewswire/ -- NVA237 has been filed for marketing authorisation by Novartis with the European Medicines Agency (EMA) under the brand-name Seebri® Breezhaler®, triggering a $5m milestone payment to Sosei Studies show investig